Related Experiment Video
Updated: Aug 1, 2026

10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Aquaporin 5-deficient mouse lungs are hyperresponsive to cholinergic stimulation
C M Krane1, C N Fortner, A R Hand
1Department of Molecular Genetics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0524, USA.
Summary
Aquaporin 5 (AQP5) knockout mice exhibit enhanced airway hyperresponsiveness, suggesting AQP5 plays a role in regulating bronchoconstriction and potentially asthma-related genetic loci.
Area of Science:
- Pulmonary Physiology
- Molecular Biology
- Immunology
Background:
- Aquaporin 5 (AQP5) is a major water channel in lung alveolar type I cells, but its precise function remains unclear.
- AQP5 expression is also found in alveolar type II cells and airway epithelium, suggesting broader roles.
Purpose of the Study:
- To investigate the role of AQP5 in pulmonary physiology, specifically its influence on bronchoconstriction.
- To analyze the function of AQP5 using knockout mouse models.
Main Methods:
- Immunohistochemical staining to determine AQP5 expression patterns in mouse lungs.
- Assessment of pulmonary function in Aqp5 knockout (Aqp5(-/-)) and wild-type (Aqp5(+/+)) mice using acetylcholine and methacholine challenges.
- Analysis of tracheal smooth muscle contractility and surfactant protein B levels.
Main Results:
- Aqp5(-/-) mice displayed significantly increased concentration-dependent bronchoconstriction compared to Aqp5(+/+) mice.
- Elevated total lung resistance and decreased dynamic lung compliance were observed in Aqp5(-/-) mice.
- Enhanced Penh measurements indicated greater bronchoconstriction in Aqp5(-/-) mice upon methacholine challenge.
- The observed hyperreactivity was independent of tracheal smooth muscle contractility or surfactant protein B levels.
Conclusions:
- AQP5 plays a novel role in modulating bronchoconstriction, influencing airway hyperresponsiveness.
- The Aqp5 gene's location on mouse chromosome 15 aligns with genetic loci associated with asthma and airway hyperresponsiveness, highlighting its potential clinical relevance.
Related Concept Videos
Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
Cholinergic Antagonists: Pharmacological Actions
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...

